TIFFANY LEISTER: Open Payments
NPI 1629302823 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,923 in 131 payments from 19 companies in 2025. Trend: 2023 $2,347 · 2024 $2,570 · 2025 $2,923
Food & beverage: $2,923
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 24 | $372 |
| Abbott Laboratories | 14 | $336 |
| Philips North America LLC | 16 | $317 |
| E.R. Squibb & Sons, L.L.C. | 13 | $239 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $229 |
| Alnylam Pharmaceuticals Inc. | 4 | $219 |
| AstraZeneca Pharmaceuticals LP | 7 | $202 |
| Amgen Inc. | 6 | $160 |
| Novartis Pharmaceuticals Corporation | 4 | $156 |
| Merck Sharp & Dohme LLC | 6 | $129 |
Products named: Ambulatory Monitoring & Diagnostics Undivided, CAMZYOS, Kerendia, AMVUTTRA, VYNDAQEL, AVEIR, ELIQUIS, Repatha.
Industry payments across MS — which companies pay providers there.
